清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Facile fabrications of poly (acrylic acid)-mesoporous zinc phosphate/polydopamine Janus nanoparticles as a biosafe photothermal therapy agent and a pH/NIR-responsive drug carrier

材料科学 光热治疗 纳米颗粒 丙烯酸 介孔材料 杰纳斯 药物输送 纳米技术 磷酸锌 化学工程 聚合物 共聚物 有机化学 催化作用 复合材料 化学 冶金 工程类
作者
Wei Gao,Xinyuan Yu,Chunpeng Zhang,Haoyang Du,Shiya Yang,Hao Wang,Jiuxin Zhu,Yakun Luo,Manjie Zhang
出处
期刊:Acta Biomaterialia [Elsevier]
卷期号:187: 328-339 被引量:7
标识
DOI:10.1016/j.actbio.2024.08.020
摘要

Balancing biocompatibility and drug-loading efficiency in nanoparticles presents a significant challenge. In this study, we describe the facile fabrication of poly (acrylic acid)-mesoporous zinc phosphate/polydopamine (PAA-mZnP/PDA) Janus nanoparticles (JNPs). The PDA half-shell itself can serve as a photothermal agent for photothermal therapy (PTT), as well as to offers sites for polyethylene glycol (PEG) to enhance biocompatibility. Concurrently, the mesoporous ZnP core allows high loading of doxorubicin (DOX) for chemotherapy and the Cy5.5 dye for fluorescence imaging. The resultant PAA-mZnP/PDA-PEG JNPs exhibit exceptional biocompatibility, efficient drug loading (0.5 mg DOX/1 mg JNPs), and dual pH/NIR-responsive drug release properties. We demonstrate the JNPs' satisfactory anti-cancer efficacy, highlighting the synergistic effects of chemotherapy and PTT. Furthermore, the potential for synergistic fluorescence imaging-guided chemo-phototherapy in cancer treatment is illustrated. Thus, this work exemplifies the development of biosafe, multifunctional JNPs for advanced applications in cancer theranostics. STATEMENT OF SIGNIFICANCE: Facile fabrication of monodispersed nanomedicine with multi-cancer killing modalities organically integrated is nontrivial and becomes more challenging under the biocompatibility requirement that is necessary for the practical applications of nanomedicines. In this study, we creatively designed PAA-mZnP/PDA JNPs and fabricated them under mild conditions. Our method reliably yields uniform JNPs with excellent monodispersity. To maximize functionalities, we achieve fourfold advantages including efficient drug/fluorescent dye loading, PTT, pH/NIR dual-responsive properties, and optimal biocompatibility. The as-fabricated JNPs exhibit satisfactory anti-cancer performance both in vitro and in vivo, and demonstrate the potential of JNPs in fluorescence imaging-guided synergistic cancer chemo-phototherapy. Overall, our research establishes a pathway in versatile inorganic/polymer JNPs for enhanced cancer diagnosis and therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李爱国应助Daisy采纳,获得30
1秒前
monkeytong1发布了新的文献求助10
6秒前
无情的琳发布了新的文献求助10
9秒前
复杂的夜香完成签到 ,获得积分10
11秒前
忘忧Aquarius完成签到,获得积分10
11秒前
喜悦的唇彩完成签到,获得积分10
13秒前
16秒前
量子星尘发布了新的文献求助10
19秒前
theo完成签到 ,获得积分10
20秒前
31秒前
冷静的尔竹完成签到,获得积分10
36秒前
creep2020完成签到,获得积分10
42秒前
muriel完成签到,获得积分0
43秒前
西山菩提完成签到,获得积分10
47秒前
奈思完成签到 ,获得积分10
47秒前
热情依白应助科研通管家采纳,获得10
48秒前
热情依白应助科研通管家采纳,获得10
48秒前
zozo完成签到,获得积分10
48秒前
53秒前
Daisy发布了新的文献求助30
1分钟前
量子星尘发布了新的文献求助30
1分钟前
无情的琳发布了新的文献求助10
1分钟前
大模型应助灵巧慕青采纳,获得10
1分钟前
1分钟前
灵巧慕青完成签到,获得积分10
1分钟前
1分钟前
Daisy完成签到,获得积分10
1分钟前
灵巧慕青发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
monkeytong1完成签到,获得积分10
1分钟前
1分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
nick完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5724311
求助须知:如何正确求助?哪些是违规求助? 5286807
关于积分的说明 15299779
捐赠科研通 4872276
什么是DOI,文献DOI怎么找? 2616831
邀请新用户注册赠送积分活动 1566672
关于科研通互助平台的介绍 1523608